Clinical Trial Update: Communicating With Patients on Cancer Resistance to Treatment: the Development of a Communication Tool. (HECTOR) [NA]

View source ↗

Summary

The document reports the completion of a study to develop a patient communication tool (HECTOR) for discussing cancer treatment resistance, applicable to severa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Luminal Breast Cancer
• Triple-negative Breast Cancer
• Uveal Melanoma

Snippet

Sponsor: Institut Curie | Conditions: Metastatic Uveal Melanoma, Triple Negative Breast Cancer | NA | Status: COMPLETED